GIULIANO BETONI GUGLIELMETTI
Projetos de Pesquisa
Unidades Organizacionais
Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Faculdade de Medicina - Médico
LIM/55 - Laboratório de Urologia, Hospital das Clínicas, Faculdade de Medicina
LIM/55 - Laboratório de Urologia, Hospital das Clínicas, Faculdade de Medicina
6 resultados
Resultados de Busca
Agora exibindo 1 - 6 de 6
- Case 297: Mucinous Adenocarcinoma of the Prostate(2022) KANAS, Alexandre Fligelman; FENELON, Sandro Santos; SANTOS, Joao Manoel Miranda Magalhaes; COELHO, Rafael Ferreira; GUGLIELMETTI, Giuliano Betoni; NAHAS, William Carlos; VIANA, Publio Cesar Cavalcante
- Robot-assisted simple prostatectomy: the evolution of a surgical technique(2021) RODRIGUES, Gilberto J.; SAWCZYN, Guilherme V.; GUGLIELMETTI, Giuliano B.; FAZOLI, Arnaldo J. C.; TANURE, Luis H. R.; NAHAS, William C.; COELHO, Rafael F.
- Robot - assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor(2017) TORRICELLI, Fabio C. M.; JARDIM, Denis; GUGLIELMETTI, Giuliano B.; PATEL, Vipul; COELHO, Rafael F.
- Current concepts in multiparametric magnetic resonance imaging for active surveillance of prostate cancer(2018) CAVALCANTE, Alexandre; VIANA, Publio Cesar C.; GUGLIELMETTI, Giuliano B.; PONTES, Jose; NONEMACHER, Henrique; CORDEIRO, Mauricio D.; BEZERRA, Regis Otaviano F.; COELHO, Rafael F.; NAHAS, William Carlos
- Case 297(2021) KANAS, Alexandre Fligelman; FENELON, Sandro Santos; SANTOS, Joao Manoel Miranda Magalhaes; COELHO, Rafael Ferreira; GUGLIELMETTI, Giuliano Betoni; NAHAS, William Carlos; VIANA, Publio Cesar CavalcanteHistory A 70-year-old man was referred to our institution with chronic obstructive urinary symptoms and constipation for 2 years before admission. His medical history was unremarkable. Outside laboratory tests revealed an elevated serum prostate-specific antigen level (21.7 ng/mL [normal range, 0.00-4.00 ng/mL]), and urinalysis results were negative. He was admitted for evaluation of possible prostate cancer. The patient reported no specific symptoms of infection and denied fever, dysuria, hematuria, and abdominal pain. He had no family history of prostate cancer. On physical examination, he was afebrile, and the digital rectal examination was not painful. These findings were evidence of an enlarged prostate and a hard multilobulated mass, which was palpable bilaterally. The urologic team performed MRI of the prostate (Figs 1-4)
- Robot-assisted laparoscopic radical prostatectomy with early retrograde release of the neurovascular bundle and endopelvic fascia sparing(2017) ALBUQUERQUE, George Augusto Monteiro Lins de; GUGLIELMETTI, Giuliano Betoni; CORDEIRO, Mauricio Dener; NAHAS, William Carlos; COELHO, Rafael FerreiraIntroduction: Robotic-assisted radical prostatectomy (RAP) is the dominant minimally invasive surgical treatment for patients with localized prostate cancer. The introduction of robotic assistance has the potential to improve surgical outcomes and reduce the steep learning curve associated with conventional laparoscopic radical prostatectomy. The purpose of this video is to demonstrate the early retrograde release of the neurovascular bundle without open the endopelvic fascia during RAP. Materials and Methods: A 51-year old male, presenting histological diagnosis of prostate adenocarcinoma, Gleason 6 (3+3), in 4 cores of 12, with an initial PSA=3.41ng/dl and the digital rectal examination demonstrating a prostate with hardened nodule in the right lobe of the prostate base (clinical stage T2a). Surgical treatment with the robot-assisted technique was offered as initial therapeutic option and the critical technical point was the early retrograde release of the neurovascular bundle with endopelvic fascia preservation, during radical prostatectomy. Results: The operative time was of 89 minutes, blood loss was 100ml. No drain was left in the peritoneal cavity. The patient was discharged within 24 hours. There were no intraoperative or immediate postoperative complications. The pathological evaluation revealed prostate adenocarcinoma, Gleason 6, with free surgical margins and seminal vesicles free of neoplastic involvement (pathologic stage T2a). At 3-month-follow-up, the patient lies with undetectable PSA, continent and potent. Conclusion: This is a feasible technique combining the benefits of retrograde release of the neurovascular bundle, the preservation of the pubo-prostatic collar and the preservation of the antero-lateral cavernous nerves.